Key insights into the industry's views on royalty rates and their impact in determining the value of a deal.
The Royalty Rate Report is the definitive guide for the industry and provides in-depth analysis of one of the most important but elusive components of a biopharma deal - the royalty rate.
- Gain opinions and advice from leading industry dealmakers who share their thoughts on royalty rates
- Receive guidance on the best methodologies to use including benchmarking and advanced valuation techniques when calculating royalty rates for vital decision making
- Understand the differences in perception of value between biotechnology companies and pharmaceutical companies and how that impacts the value of a deal
- Review actual royalty rate data supported by case histories and be better informed before negotiating your next deal
- Access to a comprehensive appendix includes the PharmaDeals' industry survey and a listing of all royalty reporting deals from the last ten years
- One year subscription to the report published on the interactive online IMS Syndicated Analytics Library
- IMS Syndicated Analytics Library offers full searchability including cut and create your own report, export tables, figures and whole chapters into Excel, PowerPoint and Word
- Nine language automatic translation - choose to view report in French, German, Chinese, Italian, Spanish, Japanese, Portuguese, Korean or Russian